Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 5/13/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Elaine R. Mardis

Wrong Dr. Elaine R. Mardis?

Professor of Genetics

Phone: (314) ***-****  
Email: e***@***.edu
Local Address: St. Louis, Missouri, United States
Washington University School of Medicine
 
Background

Employment History

Board Memberships and Affiliations

Education

  • PhD
  • B.S. degree , zoology
    University of Oklahoma
  • Ph.D. , Chemistry and Biochemistry
  • BS , Zoology
    University of Oklahoma
168 Total References
Web References
WU-NGS Profile - PGRN Web Site - Confluence
pgrn.org, 13 May 2015 [cached]
Elaine Mardis, Ph.D.
Host Institution
The Genome Center, Washington University School of Medicine
...
Elaine Mardis, Ph.D. Associate Professor Co-Director of The Genome Center Email: emardis@wustl.edu Phone: (314) 286-1924
...
Executive Assistant to Dr. Mardis at The Genome Center Email: jgrigsby@wustl.edu Phone: (314) 286-1924
An Expert Interview with Elaine R. ...
www.stsiweb.org, 21 Mar 2011 [cached]
An Expert Interview with Elaine R. Mardis, Ph.D.
...
In an interview with Medscape Medical News, Elaine R. Mardis, PhD, co-director of The Genome Center and associate professor of genetics and molecular microbiology at Washington University School of Medicine, talks about her recent presentation on whole-genome sequencing in breast cancer at the The Future of Genomic Medicine (FGM) IV conference, held March 3 and 4 in La Jolla, California, and sponsored by Scripps Translational Science Institute.
Medscape: You've presented at the FGM meetings for the past 2 years. Was your topic this year closely related to the material you talked about last year?
Dr. Mardis: The presentation that I gave was really a follow-on to a slide in last year's talk, in which I had primarily focused on our work in AML.
...
Dr. Mardis: It's my understanding that about 70% to 75% of all breast cancers are ER-positive.
...
Dr. Mardis: Absolutely!
...
Dr. Mardis: The first genome that we sequenced was an AML genome of a patient [Nature. 2008;456:66-72]. It has been our focus for whole-genome sequencing.
...
Dr. Mardis: Basically, to understand what's unique to the cancer, you have to have the comparative normal from that patient.
...
Dr. Mardis : I think we have ways of looking at that, but I don't know that we've been incredibly systematic about it.
...
Dr. Mardis: In the long run, yes.
...
Dr. Mardis: The person who really stole the show, and rightfully so, is the guy from T-Gen [Translational Genomics Research Institute], Dan Von Hoff [whose talk was entitled The Oncologists' 6th Vital Sign - A Context of Vulnerability].
Scientific Advisory Board - Ingenuity
www.ingenuity.com, 21 Dec 2014 [cached]
Elaine Mardis
...
Elaine R. Mardis, Ph.D. Professor of Genetics and Molecular Microbiology. Co-director, The Genome Institute at Washington University School of Medicine.
Elaine Mardis graduated Phi Beta Kappa from the University of Oklahoma with a B.S. degree in zoology. She then completed her Ph.D. in Chemistry and Biochemistry in 1989, also at Oklahoma. Following graduation, Dr. Mardis was a senior research scientist for four years at BioRad Laboratories in Hercules, CA.
In 1993, Dr. Mardis joined The Genome Institute at Washington University School of Medicine. As Director of Technology Development, she helped create methods and automation pipelines for sequencing the Human Genome. She currently orchestrates the Center's efforts to explore massively parallel sequencing technologies and to transition them into production sequencing capabilities as well as new applications.
Dr. Mardis has research interests in the application of DNA sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. She also is interested in facilitating the translation of basic science discoveries about human disease into the clinical setting.
Dr. Mardis serves as an editorial board member of Molecular Cancer Research, Genome Research and Molecular Oncology, and acts as a reviewer for Nature, the New England Journal of Medicine, Cell and Genome Research. She serves on the scientific advisory boards of Pacific Biosciences, Inc., DNA Nexus, and ZS Genetics. Dr. Mardis received the Scripps Translational Research award for her work on cancer genomics in 2010, and was named a Distinguished Alumni of the University of Oklahoma College of Arts and Sciences for 2011. She is the former chair of Basic and Translational Sciences for the American College of Surgeons Oncology Group (ACOSOG).
ZS Genetics Management Team
www.zsgenetics.com, 24 Oct 2014 [cached]
Elaine R. Mardis, PhD (SAB Chair) Dr. Elaine Mardis graduated Phi Beta Kappa from the University of Oklahoma with a B.S. degree in zoology. She then completed her Ph.D. in Chemistry and Biochemistry in 1989, also at Oklahoma. Following graduation, Dr. Mardis was a senior research scientist for four years at BioRad Laboratories in Hercules, CA.
In 1993, Dr. Mardis joined The Genome Institute at Washington University School of Medicine. As Director of Technology Development, she helped create methods and automation pipelines for sequencing the Human Genome. She currently orchestrates the Center's efforts to explore massively parallel sequencing technologies and to transition them into production sequencing capabilities as well as new applications.
Dr. Mardis has research interests in the application of DNA sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. She also is interested in facilitating the translation of basic science discoveries about human disease into the clinical setting.
Dr. Mardis serves as an editorial board member of Molecular Cancer Research, Genome Research and Molecular Oncology, and acts as a reviewer for Nature, the New England Journal of Medicine, Cell and Genome Research. She serves on the scientific advisory boards of Qiagen Ingenuity, DNA Nexus, and ZS Genetics. Dr. Mardis received the Scripps Translational Research award for her work on cancer genomics in 2010, and was named a Distinguished Alumni of the University of Oklahoma College of Arts and Sciences for 2011. She is the former chair of Basic and Translational Sciences for the American College of Surgeons Oncology Group (ACOSOG).
Further information is available on Dr. Mardis at genome.wustl.edu/people/individual/elaine-mardis/.
The opening keynote address by Dr. ...
www.uhnres.utoronto.ca, 1 Feb 2014 [cached]
The opening keynote address by Dr. Elaine R. Mardis provided a glimpse into the future of personalized medicine. As Director of Technology Development for the Genome Institute (Washington University), she established an integrated and cutting-edge sequencing platform that enabled her, along with collaborators and clinicians, to create customized treatment protocols for patients with unresponsive cancers.
Other People with the name "Mardis":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304